8226/S, 8226/S-CR, 8226/S-ATOR05 cells, as well as 8226/S-ATOR05 cells cultured in the absence of ATO for 7, 14, 21, 35, and 50 days were treated with the indicated concentrations of ATO, Mel, or Dox for 24 h and apoptosis was determined by flow cytometry and graphed as percent of control Annexin V positive cells versus drug concentration
This distinction matters because it clarifies that GLP-1 therapy addresses behavioral and neurological weight drivers, not the metabolic deficit created by thyroidectomy
This is not an approval announcement
however, because obesity and physical inactivity are strongly correlated with the condition, it is reasonable to expect that increasing physical activity and encouraging weight loss would be helpful
Depending on the equipment variant, the device dimensions are based on a robust and compact 19 or 19 housing
Earls, H